Samsung Electronics announced on the 10th that it will participate in ‘WHX Dubai 2026,’ the largest medical device exhibition in the Middle East, held in Dubai from February 9 to 12, and present its expanded portfolio of medical device products.

At this exhibition, the Samsung Electronics Medical Device Business Division and Samsung Medison will unveil for the first time worldwide the new ultrasound diagnostic systems ‘V4’ and ‘EVO Q10’, and introduce the radiology‑dedicated premium ultrasound diagnostic system ‘R20’ to the Middle East market for the first time.

The new V4 is a next‑generation ultrasound diagnostic system that enhances completeness by designing the circuit and structure as a single integrated system. It significantly improves power efficiency, reducing power consumption by about 35% compared with existing products, and features high‑resolution imaging combined with various artificial intelligence (AI) diagnostic assistance functions.

In particular, V4 is described as the world’s first fanless ultrasound diagnostic system that can effectively control internal heat without a cooling fan. The absence of a fan eliminates noise, providing a quiet examination environment, and prevents outside air and dust from entering the device, thereby extending its service life.

EVO Q10 is a laptop‑type ultrasound diagnostic system that enhances portability based on the performance of V4. It is designed to be lightweight and compact so that fast and accurate diagnoses can be made in various settings such as emergency rooms, outpatient clinics, and mobile medical services. It is said to have improved ease of disinfection and maintenance by combining a more durable exterior with water‑resistance certification.

During the exhibition, Samsung will demonstrate technologies that can be used in real clinical settings, including a function that shares the EVO Q10 screen in real time with other displays, and AI functions that automatically recognize the heart to assist with measurement and diagnosis.

Samsung will also unveil AI X‑ray technology that reduces radiation exposure while improving the efficiency of image reading. It will additionally showcase X‑ray equipment equipped with a function that automatically checks the imaging area, as well as high‑performance detectors that provide lightweight and clear images.

On the third day of the event, the ‘Samsung AI Symposium’ will be held, where medical experts from Europe and the Middle East will share cases of using Samsung’s AI diagnostic technologies in actual clinical practice. Live demonstrations will also be conducted in liver and abdominal diagnostics and obstetrics and gynecology.

Samsung plans to use this exhibition as an opportunity to expand cooperation with hospitals, government agencies, and local partners in the Middle East and actively seek new business opportunities in medical devices.

Yoo Kyu-tae, Head of the Medical Device Business Division at Samsung Electronics and CEO of Samsung Medison, said, “The Middle East is a very important market for Samsung’s medical device business,” adding, “Samsung will enhance the competitiveness of local medical staff through AI‑based diagnostic solutions and pursue meaningful growth in the Middle East market.”

Popular News